Inhibitor Therapeutics, Inc. Quarterly Return On Assets in % from Q2 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Inhibitor Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2014 to Q3 2024.
  • Inhibitor Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -40.6 %, a 141% decline year-over-year.
  • Inhibitor Therapeutics, Inc. annual Return On Assets for 2023 was -30.6 %, a 108% decline from 2022.
  • Inhibitor Therapeutics, Inc. annual Return On Assets for 2022 was 399 %.
  • Inhibitor Therapeutics, Inc. annual Return On Assets for 2021 was -280 %, a 43.7% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -40.6 -139 -141% Jul 1, 2024 Sep 30, 2024
Q2 2024 -36 -170 -127% Apr 1, 2024 Jun 30, 2024
Q1 2024 -34.7 -238 -117% Jan 1, 2024 Mar 31, 2024
Q4 2023 -30.6 -430 -108% Oct 1, 2023 Dec 31, 2023
Q3 2023 98.7 +618 Jul 1, 2023 Sep 30, 2023
Q2 2023 134 +582 Apr 1, 2023 Jun 30, 2023
Q1 2023 204 +513 Jan 1, 2023 Mar 31, 2023
Q4 2022 399 +679 Oct 1, 2022 Dec 31, 2022
Q3 2022 -519 -262 -102% Jul 1, 2022 Sep 30, 2022
Q2 2022 -448 -14.6 -3.38% Apr 1, 2022 Jun 30, 2022
Q1 2022 -309 +234 +43.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -280 +218 +43.7% Oct 1, 2021 Dec 31, 2021
Q3 2021 -257 +148 +36.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 -433 -165 -61.3% Apr 1, 2021 Jun 30, 2021
Q1 2021 -543 -354 -186% Jan 1, 2021 Mar 31, 2021
Q4 2020 -498 -309 -163% Oct 1, 2020 Dec 31, 2020
Q3 2020 -405 -181 -80.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 -269 -25.8 -10.6% Apr 1, 2020 Jun 30, 2020
Q1 2020 -190 +113 +37.3% Jan 1, 2020 Mar 31, 2020
Q4 2019 -190 +103 +35.1% Oct 1, 2019 Dec 31, 2019
Q3 2019 -224 +62 +21.6% Jul 1, 2019 Sep 30, 2019
Q2 2019 -243 +34.6 +12.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 -303 -75.9 -33.5% Jan 1, 2019 Mar 31, 2019
Q4 2018 -292 +2.98 +1.01% Oct 1, 2018 Dec 31, 2018
Q3 2018 -286 -80.3 -39% Jul 1, 2018 Sep 30, 2018
Q2 2018 -277 -78.1 -39.2% Apr 1, 2018 Jun 30, 2018
Q1 2018 -227 -44.7 -24.5% Jan 1, 2018 Mar 31, 2018
Q4 2017 -295 -126 -74.3% Oct 1, 2017 Dec 31, 2017
Q3 2017 -206 +3.36 +1.6% Jul 1, 2017 Sep 30, 2017
Q2 2017 -199 +45.5 +18.6% Apr 1, 2017 Jun 30, 2017
Q1 2017 -182 +152 +45.5% Jan 1, 2017 Mar 31, 2017
Q4 2016 -169 +163 +49.1% Oct 1, 2016 Dec 31, 2016
Q3 2016 -210 +143 +40.5% Jul 1, 2016 Sep 30, 2016
Q2 2016 -245 +174 +41.5% Apr 1, 2016 Jun 30, 2016
Q1 2016 -335 +1.1K +76.6% Jan 1, 2016 Mar 31, 2016
Q4 2015 -332 +996 +75% Oct 1, 2015 Dec 31, 2015
Q3 2015 -352 +1.42K +80.1% Jul 1, 2015 Sep 30, 2015
Q2 2015 -419 +4.37K +91.3% Apr 1, 2015 Jun 30, 2015
Q1 2015 -1.43K Jan 1, 2015 Mar 31, 2015
Q4 2014 -1.33K Oct 1, 2014 Dec 31, 2014
Q3 2014 -1.77K Jul 1, 2014 Sep 30, 2014
Q2 2014 -4.79K Apr 1, 2014 Jun 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.